Literature DB >> 32081286

Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk.

Yoriko Heianza1, Wenjie Ma2, Joseph A DiDonato3, Qi Sun4, Eric B Rimm5, Frank B Hu5, Kathryn M Rexrode6, JoAnn E Manson7, Lu Qi8.   

Abstract

BACKGROUND: A gut-microbial metabolite, trimethylamine N-oxide (TMAO), has been associated with coronary atherosclerotic burden. No previous prospective study has addressed associations of long-term changes in TMAO with coronary heart disease (CHD) incidence.
OBJECTIVES: The purpose of this study was to investigate whether 10-year changes in plasma TMAO levels were significantly associated with CHD incidence.
METHODS: This prospective nested case-control study included 760 healthy women at baseline. Plasma TMAO levels were measured both at the first (1989 to 1990) and the second (2000 to 2002) blood collections; 10-year changes (Δ) in TMAO were calculated. Incident cases of CHD (n = 380) were identified after the second blood collection through 2016 and were matched to controls (n = 380).
RESULTS: Regardless of the initial TMAO levels, 10-year increases in TMAO from the first to second blood collection were significantly associated with an increased risk of CHD (relative risk [RR] in the top tertile: 1.58 [95% confidence interval (CI): 1.05 to 2.38]; RR per 1-SD increment: 1.33 [95% CI: 1.06 to 1.67]). Participants with elevated TMAO levels (the top tertile) at both time points showed the highest RR of 1.79 (95% CI: 1.08 to 2.96) for CHD as compared with those with consistently low TMAO levels. Further, we found that the ΔTMAO-CHD relationship was strengthened by unhealthy dietary patterns (assessed by the Alternate Healthy Eating Index) and was attenuated by healthy dietary patterns (p interaction = 0.008).
CONCLUSIONS: Long-term increases in TMAO were associated with higher CHD risk, and repeated assessment of TMAO over 10 years improved the identification of people with a higher risk of CHD. Diet may modify the associations of ΔTMAO with CHD risk.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coronary heart disease; diet; gut-microbial metabolites; prospective cohort study; risk factors

Mesh:

Substances:

Year:  2020        PMID: 32081286      PMCID: PMC8140616          DOI: 10.1016/j.jacc.2019.11.060

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  42 in total

1.  Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.

Authors:  W Zhu; J A Buffa; Z Wang; M Warrier; R Schugar; D M Shih; N Gupta; J C Gregory; E Org; X Fu; L Li; J A DiDonato; A J Lusis; J M Brown; S L Hazen
Journal:  J Thromb Haemost       Date:  2018-08-09       Impact factor: 5.824

2.  Gut flora-dependent metabolite Trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress.

Authors:  Yilang Ke; Dang Li; Mingming Zhao; Changjie Liu; Jia Liu; Aiping Zeng; Xiaoyun Shi; Si Cheng; Bing Pan; Lemin Zheng; Huashan Hong
Journal:  Free Radic Biol Med       Date:  2018-01-08       Impact factor: 7.376

3.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; A S Krolewski; B Rosner; R A Arky; F E Speizer; C H Hennekens
Journal:  Arch Intern Med       Date:  1991-06

4.  Alternative dietary indices both strongly predict risk of chronic disease.

Authors:  Stephanie E Chiuve; Teresa T Fung; Eric B Rimm; Frank B Hu; Marjorie L McCullough; Molin Wang; Meir J Stampfer; Walter C Willett
Journal:  J Nutr       Date:  2012-04-18       Impact factor: 4.798

5.  Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.

Authors:  Brian J Bennett; Thomas Q de Aguiar Vallim; Zeneng Wang; Diana M Shih; Yonghong Meng; Jill Gregory; Hooman Allayee; Richard Lee; Mark Graham; Rosanne Crooke; Peter A Edwards; Stanley L Hazen; Aldons J Lusis
Journal:  Cell Metab       Date:  2013-01-08       Impact factor: 27.287

6.  Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women.

Authors:  G A Colditz; P Martin; M J Stampfer; W C Willett; L Sampson; B Rosner; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1986-05       Impact factor: 4.897

7.  Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.

Authors:  Arash Haghikia; Xinmin S Li; Thomas G Liman; Nils Bledau; David Schmidt; Friederike Zimmermann; Nicolle Kränkel; Christian Widera; Kristina Sonnenschein; Aiden Haghikia; Karin Weissenborn; Daniela Fraccarollo; Markus M Heimesaat; Johann Bauersachs; Zeneng Wang; Weifei Zhu; Udo Bavendiek; Stanley L Hazen; Matthias Endres; Ulf Landmesser
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

8.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.

Authors:  Zeneng Wang; Elizabeth Klipfell; Brian J Bennett; Robert Koeth; Bruce S Levison; Brandon Dugar; Ariel E Feldstein; Earl B Britt; Xiaoming Fu; Yoon-Mi Chung; Yuping Wu; Phil Schauer; Jonathan D Smith; Hooman Allayee; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Nature       Date:  2011-04-07       Impact factor: 49.962

9.  Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis.

Authors:  Ji Miao; Alisha V Ling; Praveen V Manthena; Mary E Gearing; Mark J Graham; Rosanne M Crooke; Kevin J Croce; Ryan M Esquejo; Clary B Clish; David Vicent; Sudha B Biddinger
Journal:  Nat Commun       Date:  2015-04-07       Impact factor: 14.919

10.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.

Authors:  Robert A Koeth; Zeneng Wang; Bruce S Levison; Jennifer A Buffa; Elin Org; Brendan T Sheehy; Earl B Britt; Xiaoming Fu; Yuping Wu; Lin Li; Jonathan D Smith; Joseph A DiDonato; Jun Chen; Hongzhe Li; Gary D Wu; James D Lewis; Manya Warrier; J Mark Brown; Ronald M Krauss; W H Wilson Tang; Frederic D Bushman; Aldons J Lusis; Stanley L Hazen
Journal:  Nat Med       Date:  2013-04-07       Impact factor: 53.440

View more
  30 in total

1.  Effects of a diet based on the Dietary Guidelines on vascular health and TMAO in women with cardiometabolic risk factors.

Authors:  Sridevi Krishnan; Erik R Gertz; Sean H Adams; John W Newman; Theresa L Pedersen; Nancy L Keim; Brian J Bennett
Journal:  Nutr Metab Cardiovasc Dis       Date:  2021-09-20       Impact factor: 4.222

Review 2.  The Use of Healthy Eating Index 2015 and Healthy Beverage Index for Predicting and Modifying Cardiovascular and Renal Outcomes.

Authors:  Lale A Ertuglu; Atalay Demiray; Baris Afsar; Alberto Ortiz; Mehmet Kanbay
Journal:  Curr Nutr Rep       Date:  2022-04-27

3.  Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women.

Authors:  Gang Liu; Jun Li; Yanping Li; Yang Hu; Adrian A Franke; Liming Liang; Frank B Hu; Andrew T Chan; Kenneth J Mukamal; Eric B Rimm; Qi Sun
Journal:  Am J Clin Nutr       Date:  2021-07-01       Impact factor: 7.045

4.  Interplay between diet and gut microbiome, and circulating concentrations of trimethylamine N-oxide: findings from a longitudinal cohort of US men.

Authors:  Eric B Rimm; Qi Sun; Jun Li; Yanping Li; Kerry L Ivey; Dong D Wang; Jeremy E Wilkinson; Adrian Franke; Kyu Ha Lee; Andrew Chan; Curtis Huttenhower; Frank B Hu
Journal:  Gut       Date:  2021-04-29       Impact factor: 23.059

Review 5.  Systems biology in cardiovascular disease: a multiomics approach.

Authors:  Abhishek Joshi; Marieke Rienks; Konstantinos Theofilatos; Manuel Mayr
Journal:  Nat Rev Cardiol       Date:  2020-12-18       Impact factor: 32.419

6.  Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.

Authors:  W H Wilson Tang; Xinmin S Li; Yuping Wu; Zeneng Wang; Kay-Tee Khaw; Nicholas J Wareham; Max Nieuwdorp; S Matthijs Boekholdt; Stanley L Hazen
Journal:  Am Heart J       Date:  2021-02-21       Impact factor: 5.099

7.  Circulating trimethylamine N-oxide in association with diet and cardiometabolic biomarkers: an international pooled analysis.

Authors:  Jae Jeong Yang; Xiao-Ou Shu; David M Herrington; Steven C Moore; Katie A Meyer; Jennifer Ose; Cristina Menni; Nicholette D Palmer; Heather Eliassen; Sei Harada; Ioanna Tzoulaki; Huilian Zhu; Demetrius Albanes; Thomas J Wang; Wei Zheng; Hui Cai; Cornelia M Ulrich; Marta Guasch-Ferré; Ibrahim Karaman; Myriam Fornage; Qiuyin Cai; Charles E Matthews; Lynne E Wagenknecht; Paul Elliott; Robert E Gerszten; Danxia Yu
Journal:  Am J Clin Nutr       Date:  2021-05-08       Impact factor: 8.472

Review 8.  Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.

Authors:  Doudou Li; Ying Lu; Shuai Yuan; Xiaxia Cai; Yuan He; Jie Chen; Qiong Wu; Di He; Aiping Fang; Yacong Bo; Peige Song; Debby Bogaert; Kostas Tsilidis; Susanna C Larsson; Huanling Yu; Huilian Zhu; Evropi Theodoratou; Yimin Zhu; Xue Li
Journal:  Am J Clin Nutr       Date:  2022-07-06       Impact factor: 8.472

9.  Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases.

Authors:  Fernando F Anhê; Benjamin A H Jensen; Lais Rossi Perazza; André Tchernof; Jonathan D Schertzer; André Marette
Journal:  J Lipid Atheroscler       Date:  2021-02-09

10.  Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction.

Authors:  Ying Han; Zhaowei Gong; Guizhi Sun; Jing Xu; Changlu Qi; Weiju Sun; Huijie Jiang; Peigang Cao; Hong Ju
Journal:  Front Microbiol       Date:  2021-07-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.